Brii Biosciences
Blood & Organ Banks · North Carolina, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
110 N Corcoran St Ste 5-110, Durham, Nor...Phone Number
(919) 240-5605Website
www.briibio.comRevenue
<$5 MillionStock Symbol
2137Industry
About Brii Biosciences
Brii Biosciences is a biotechnology company focused on developing innovative medicines to address significant health conditions, particularly in the fields of infectious diseases and neurology. The company utilizes RNA technology to create differentiated treatment options, including monoclonal antibodies for COVID-19 and therapies for chronic hepatitis B. Their target clients include healthcare providers and patients in China and globally, as they aim to bring novel therapies to those in need. Brii Biosciences is recognized for its commitment to scientific innovation and public health solutions.Explore more
Brii Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Brii Biosciences
Compare insights from companies similar to Brii Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Brii Biosciences Tech Stack
A closer look at the technologies used by Brii Biosciences
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Brii Biosciences
Sign Up For FreeTo access detailed company insights
Brii Biosciences is a biotechnology company focused on developing innovative medicines to address significant health conditions, particularly in the fields of infectious diseases and neurology. The company utilizes RNA technology to create differentiated treatment options, including monoclonal antibodies for COVID-19 and therapies for chronic hepat... Read More
